The post Inside Bitter Real Estate Battle Over Late Guggenheim Exec's $400 Million Estate—as His Former Mansion Is Listed for ...
Guggenheim lowered the firm’s price target on Regeneron (REGN) to $950 from $1,200 and keeps a Buy rating on the shares. The firm, which is ...
Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that David Margulies has joined the firm’s Equities Sales & Trading group as a ...